Spring Creek Healthcare Systems, Inc.(fka SCRK)

[pania]

SCRK Report – Get Ready
Posted on February 28, 2011 by admin

besttoppennystocks Newsletter

Hello Subscribers, Good evening, we’re looking forward to an exciting start to this upcoming week. SCRK has the potential to be EXPLOSIVE on Monday, so place it on your watchlist immediately and watch it closely tomorrow morning.

Below is the full report on Spring Creek Healthcare Systems, Inc. (OTCBB: SCRK):

Spring Creek Healthcare Systems, Inc. is a healthcare solutions company distributing cutting edge solutions for the medical, pharmaceutical and healthcare markets to resellers and consumers worldwide.

One of Spring Creek’s subsidiaries, DelRX, maintains exclusive rights to produce, market and sell products administered through an innovative oral drug delivery system.

After the close on Friday SCRK announced MAJOR news pertaining to the signing of a licensing agreement between the Company and TheraBiogen, the manufacturer and distributor of TheraMax®. The full release can be viewed here:

Spring Creek HealthCare Systems, Inc. Announces Agreement for Its DelRX Pharmaceutical Corp. Subsidiary`s Proprietary Drug Delivery System This was announced Friday, AFTER THE CLOSE! So do your research quickly, because it could get VERY interesting come Monday morning.

There is a wealth of information available on SCRK’s website which can be seen here:

www.springcreekhcs.com Feel free to continue your research here:

finance.yahoo.com/qs=SCRK.OB Below is an overview of Spring Creek Healthcare Systems, Inc. (SCRK), the company’s subsidiaries, technologies, and market:

Spring Creek Healthcare Systems, Inc. (SCRK) SCRK services the healthcare market through its operating subsidiaries, which are able to leverage the distribution network of Spring Creek’s primary and 100% owned subsidiary, Stratis Healthcare, Inc.

Spring Creek brings experienced management and capital in order to actively pursue emerging opportunities in the healthcare industry dealing primarily with homeopathic and over-the-counter products. The Company’s strong management team has over 40 years of combined experience assisting and growing public companies in various industries, including entertainment, technology and healthcare.

Subsidiaries include:

• Stratis Healthcare, Inc. was created to support the logistical needs of Spring Creek Healthcare Systems and its subsidiaries in the healthcare market. Stratis’ primary focus is to distribute products to resellers and customers worldwide through both distributors and multi-channel resources.

• DelRX Pharmaceuticals Corp. is an early-stage life sciences company that is responsible for SCRK’s recent licensing agreement with McCoy Enterprises, LLC, announced on May 3, 2010. The agreement provides SCRK with exclusive rights to produce, market and sell products through an innovative drug delivery system that administers the medicine through the mouth, known medically as the buccal mucosa.

• Debride Corp. was created following SCRK’s second licensing agreement with McCoy Enterprises, LLC. The agreement provides SCRK with exclusive rights to produce market and sell products based on a fundamentally new combination approach for the treatment of open wounds and ulcers.

• Ecological Solutions Corp. produces and distributes an insect repellent based off of the same formulation as EcoBlends, a unique DEET-free blend of essential oils and natural ingredients which have proven very effective against 20 different insects.

Market Healthcare is one of the largest sectors of the U.S. economy, representing 17.3% of U.S. GDP in 2009. Total spending in healthcare has also seen significant growth, from $2.34 trillion in 2008 to $2.47 trillion in 2009, which was the largest one-year jump since 1960. Economists at the Centers for Medicare and Medicaid Services have forecast that by 2019, total U.S. spending in healthcare will be $4.5 trillion.

Investment dollars in early-stage life science companies rose 56% in the last quarter of 2009 over 2008. Life science captured the largest share of the overall venture capital in the healthcare industry during 2009, accounting for one-fourth of all deals.

Conclusion SCRK has the rights to an innovative drug delivery system that could prove valuable with the right allies which they appear to be partnering with, as evidenced in several press releases dating back to late 2010.

With such a wide business spectrum and so many different ways to generate revenues, SCRK has the potential to experience significant near term growth.

Being the first day since a MAJOR press release hit the wires, we expect Monday to be a strong day for SCRK. Look for SCRK to be a winner.

As always, we encourage you to do further research. Also, remember when you are in a position to profit it is often wise to do so.

Very Best Regards,The BTPS TeamNever invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Disclaimer& Risk Disclosure: The disclaimer is to be read and fully understood before using our site, or joining our email list.

Please note well: BestTopPennyStock employees are not registered as an Investment Advisor in any jurisdiction whatsoever. This is a Paid Advertisement..

Full disclaimer can be read at http://clicks.skem1.com/trkr/c88&g6&u=9e1a4815410aa20614f96ff8f5bd418a&p=3dabc530fff7b25e800827b6e2e2290c&t=2 DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND IN THIS REPORT.. We are not registered as a securities broker-dealer of an investment advisor either with the US Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide financial advice. Many of the companies communicated in our emails or website are developmental stage companies with little or no operating or trading history. The information contained in our alerts should be viewed as commercial advertisement and is not intended to be investment opinion. The report is not provided to any particular individual with a view toward their investment circumstances. The information contained in our alerts is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge to individuals who wish to receive them. Our advertisements and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiles based solely on information contained in our report. Individuals should assume that all information contained in the alerts about profiled companies is not trust worthy unless verified by their own independent research. Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some of all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

The profiles are a service of Market365, LLC a marketing and advertising firm that may have been compensated. All direct and third party compensation received will be disclosed within each individual alert in accordance with section 17(b) of the nineteen thirty three Securities Act. Any compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies.

BestTopPennyStocks and /or its affiliated may buy, hold, and sell securities in the companies profiled. When compensated in shares, all readers should be aware that it is our policy to liquidate all shares immediately. We reserve the right to buy or sell the shares of any of the companies mentioned in any materials we produce at any time. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. BestTopPennyStocks expects to be compensated five thousand dollars by a noncontrolling third party for the advertisement of SCRK. The third party may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company.

Forward-Looking Statements, Certain statements in this communication that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use of words such as “anticipate,” “believe,” “expect,” “future,” “may,” “will,” “would,” “should,” “plan,” “projected,” “potential,” “intend,” and similar expressions. Such forward-looking statements, involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of (the “Company”) to be materially different from those expressed or implied by such forward-looking statements.

The Company`s future operating results are dependent upon many factors, including risk factors discussed in the Company`s periodic filings with the Securities and Exchange Commission, which are available for review at http://clicks.skem1.com/trkr/c88&g6&u=5a45e80b10e4f30572e25d5d24742ba2&p=3dabc530fff7b25e800827b6e2e2290c&t=2. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in our advertisement will contain “forward looking statements” as defined under 27A of the Securities act 1933 and Section twenty one B of the Securities Exchange`s Thirty Four Act. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These “forward looking statements” are subject to a number of known and unknown risks and uncertainties outside our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company`s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating these forward looking statements included in the advertisement and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurances as to the accuracy or completeness of the information provided, including information regarding a profiled company`s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company`s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the alert, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to ,lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

Third Party Web Sites and Information BestTopPennyStocks and newsletter may provide hyperlinks to third party websites or access to third party content. BestTopPennyStocks does not control, endorse, or guarantee content found in such sites. You agree that BestTopPennyStocks is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that BestTopPennyStocks shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.

We encourage you to invest carefully and read investment information available at the websites of the SEC at www.sec.gov and FINRA at www.finra.org This message sent by: Market365 40 Memorial Hwy

New Rochelle, NY 10801